MUR
45
-8
AMAT
55
-4
TSCO
55
-3
CMI
50
-6
UHS
59
-3
EFX
57
-3
PRGO
59
-5
HES
71
-8
AA
28
-7
MSFT
53
-4
HCP
84
-2
HBAN
50
-4
WM
68
-8
SYY
56
-8
ES
34
-4
HAL
39
-19
FDX
55
-3
ETR
57
-3
RCL
66
-8
JWN
60
-5
MUR
45
-8
AMAT
55
-4
TSCO
55
-3
CMI
50
-6
UHS
59
-3
EFX
57
-3
PRGO
59
-5
HES
71
-8
AA
28
-7
MSFT
53
-4
HCP
84
-2
HBAN
50
-4
WM
68
-8
SYY
56
-8
ES
34
-4
HAL
39
-19
FDX
55
-3
ETR
57
-3
RCL
66
-8
JWN
60
-5
Financhill
Back

Neurocrine Biosciences Quote, Financials, Valuation and Earnings

9,530x the last time this happened

Here's what our expert says you should buy before April 14.
Buy
70

NBIX
Neurocrine Biosciences

Last Price:
137.49
Seasonality Move:
8.72%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Neurocrine Biosciences Price Quote

$137.49
+0.02 (+-1.01%)
(Updated: May 1, 2024 at 5:17 AM ET)

Neurocrine Biosciences Key Stats

Buy
70
Neurocrine Biosciences (NBIX) is a Buy
Day range:
$137.34 - $140.47
52-week range:
$89.04 - $148.37
Dividend yield:
0%
P/E ratio:
55.66
P/S ratio:
7.30
P/B ratio:
6.13%
Volume:
801K
Avg. volume:
839.8K
1-year change:
36.06%
Market cap:
$13.7B
Revenue:
$1.9B
EPS:
$2.42

How Much Does Neurocrine Biosciences Make?

Is Neurocrine Biosciences Growing As A Company?

Neurocrine Biosciences Stock Price Performance

What Is Neurocrine Biosciences 52-Week High & Low?

Neurocrine Biosciences Price To Free Cash Flow

Is It Risky To Buy Neurocrine Biosciences?

Is Neurocrine Biosciences Cash Flow Positive?

  • What Is NBIX Cash Flow From Operations?
    Cash flow from operations (TTM) is $389.9M
  • What Is Neurocrine Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $65.3M
  • What Is Neurocrine Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$467.1M

Neurocrine Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    NBIX return on invested capital is 12.09%
  • What Is Neurocrine Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is 9.29%
  • What Is NBIX Return On Equity?
    ROE is a measure of profitability and is 13.17%

Neurocrine Biosciences Earnings Date & Stock Price

Neurocrine Biosciences Competitors

Neurocrine Biosciences Dividend Yield

Data Unavailable

Neurocrine Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 63.64% 1.69%
Revenue: 25.05% -0.62%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 153.63
Upside from Last Price: 11.75%

Major Shareholders

  • How many NBIX shares are owned by institutional investors?
    142.6M NBIX shares are owned by institutional investors
  • How many NBIX shares are owned by insiders?
    2.3M NBIX shares are owned by insiders